As of 2025-06-02, the Relative Valuation of Zhejiang Wecome Pharmaceutical Co Ltd (300878.SZ) is 1.72 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 16.74 CNY, the upside of Zhejiang Wecome Pharmaceutical Co Ltd based on Relative Valuation is -89.7%.
The range of the Relative Valuation is 1.20 - 3.17 CNY.
| Range | Selected | |
| Trailing P/E multiples | 25.4x - 46.4x | 31.8x |
| Forward P/E multiples | 17.6x - 27.1x | 18.4x |
| Fair Price | 1.20 - 3.17 | 1.72 |
| Upside | -92.8% - -81.0% | -89.7% |
| Date | P/E |
| 2025-05-30 | 244.63 |
| 2025-05-29 | 236.30 |
| 2025-05-28 | 233.82 |
| 2025-05-27 | 234.55 |
| 2025-05-26 | 224.32 |
| 2025-05-23 | 228.56 |
| 2025-05-22 | 226.22 |
| 2025-05-21 | 228.70 |
| 2025-05-20 | 229.58 |
| 2025-05-19 | 225.34 |
| 2025-05-16 | 227.97 |
| 2025-05-15 | 222.42 |
| 2025-05-14 | 219.06 |
| 2025-05-13 | 219.79 |
| 2025-05-12 | 220.96 |
| 2025-05-09 | 217.89 |
| 2025-05-08 | 221.54 |
| 2025-05-07 | 217.74 |
| 2025-05-06 | 216.43 |
| 2025-04-30 | 210.88 |
| 2025-04-29 | 210.00 |
| 2025-04-28 | 206.78 |
| 2025-04-25 | 211.02 |
| 2025-04-24 | 216.57 |
| 2025-04-23 | 219.21 |
| 2025-04-22 | 220.23 |
| 2025-04-21 | 220.96 |
| 2025-04-18 | 216.28 |
| 2025-04-17 | 217.45 |
| 2025-04-16 | 216.57 |
| 2025-04-15 | 226.80 |
| 2025-04-14 | 228.70 |
| 2025-04-11 | 219.50 |
| 2025-04-10 | 218.91 |
| 2025-04-09 | 214.67 |
| 2025-04-08 | 214.53 |
| 2025-04-07 | 208.68 |
| 2025-04-03 | 258.66 |
| 2025-04-02 | 247.12 |
| 2025-04-01 | 252.52 |
| 2025-03-31 | 241.27 |
| 2025-03-28 | 246.24 |
| 2025-03-27 | 247.41 |
| 2025-03-26 | 256.62 |
| 2025-03-25 | 253.69 |
| 2025-03-24 | 276.93 |
| 2025-03-21 | 262.90 |
| 2025-03-20 | 234.55 |
| 2025-03-19 | 228.27 |
| 2025-03-18 | 229.58 |